NCT07740837

Brief Summary

Inserting an intravenous (IV) cannula is one of the most frequently performed procedures in clinical practice, and it is commonly experienced as painful. Before the needle is inserted, the skin is routinely cleaned with alcohol. As alcohol evaporates it cools the skin, and cooled skin is less sensitive to pain. This study examined whether accelerating that evaporation with a simple portable hand fan reduces the pain of IV cannulation. One hundred volunteers aged 18 to 65 years who required elective IV cannulation took part in the emergency department of a tertiary care city hospital. Each participant underwent two cannulations, one in each arm, within a single session. On one arm the skin was prepared with 70% isopropyl alcohol in the usual way. On the other arm the same alcohol was applied and the site was then fanned for 15 seconds with a portable hand fan before the needle was inserted. The order of the two arms was assigned randomly, so each participant served as their own comparison. Within 30 seconds of each cannulation, participants rated their pain on a 0 to 10 numeric scale. The assessor who recorded these scores did not know which arm had received the fan. The researchers also recorded whether the vein was entered on the first attempt, any skin irritation at 5 and 30 minutes, and, after both cannulations were completed, how satisfied participants were with the fan-assisted method. The purpose of the study was to determine whether this low-cost, drug-free method can make IV cannulation less painful without making it harder to place the cannula.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 3, 2026

Completed
Last Updated

August 4, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 28, 2026

Last Update Submit

August 2, 2026

Conditions

Keywords

venipuncture painintravenous cannulationlocal coolingalcohol evaporationhand fannon-pharmacological analgesiaemergency departmentcrossover trialCold TemperatureCryotherapy

Outcome Measures

Primary Outcomes (1)

  • Pain intensity during intravenous cannulation

    Self-reported pain intensity during needle insertion, measured with the Numeric Rating Scale (NRS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain. Each participant provided one score for the fan-assisted arm and one score for the standard preparation arm.

    Day 1: within 30 seconds after completion of each cannulation

Secondary Outcomes (3)

  • First-attempt cannulation success

    Day 1: at the time of each cannulation attempt

  • Skin irritation at the cannulation site

    Day 1: 5 minutes and 30 minutes after cannulation

  • Participant satisfaction with the procedure

    Day 1: immediately after completion of both cannulations

Study Arms (2)

Sequence A: Fan-assisted cooling first

EXPERIMENTAL

Participants randomised to the AB sequence first underwent intravenous cannulation on the right arm, where the site was prepared with 70% isopropyl alcohol followed by 15 seconds of fan-assisted local cooling, and then underwent cannulation on the left arm with standard alcohol preparation alone. A minimum washout period of 5 minutes separated the two cannulations.

Other: Fan-assisted local coolingOther: Standard alcohol skin preparation

Sequence B: Standard preparation first

EXPERIMENTAL

Participants randomised to the BA sequence first underwent intravenous cannulation on the right arm with standard alcohol preparation alone, and then underwent cannulation on the left arm, where the site was prepared with 70% isopropyl alcohol followed by 15 seconds of fan-assisted local cooling. A minimum washout period of 5 minutes separated the two cannulations.

Other: Fan-assisted local coolingOther: Standard alcohol skin preparation

Interventions

The cannulation site was cleaned with 2 mL of 70% isopropyl alcohol as part of standard aseptic preparation, immediately followed by 15 seconds of fanning with a portable hand fan (medium setting, airflow approximately 3 m/s) directed at the site from a distance of 10 to 15 cm, timed with a stopwatch. Cannulation was then performed with a standard 20G catheter in the antecubital fossa by a single emergency nurse with at least two years of experience. In both arms 70% isopropyl alcohol was used as routine aseptic preparation; the arms differed only in the addition of forced-air fanning.

Also known as: Evaporative cooling with hand fan, Fan-assisted alcohol evaporation, Evaporative cooling with portable hand fan
Sequence A: Fan-assisted cooling firstSequence B: Standard preparation first

The skin over the selected vein was cleaned with 70% isopropyl alcohol and allowed to dry passively, without fanning, before needle insertion. This represents routine institutional practice and served as the comparator condition.

Sequence A: Fan-assisted cooling firstSequence B: Standard preparation first

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 65 years
  • Scheduled peripheral intravenous cannulation at the antecubital region
  • Written informed consent provided

You may not qualify if:

  • Severe peripheral vascular disease (chronic venous insufficiency or history of thrombophlebitis)
  • Alcohol intolerance or allergy
  • Active dermatological disease (eczema, psoriasis, contact dermatitis)
  • Neuropathic disease that may alter pain perception
  • Analgesic use within the previous 6 hours
  • Existing pain with NRS score of 4 or higher
  • Refusal to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antalya City Hospital

Antalya, 07080, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, ProceduralAcute PainEmergencies

Interventions

Ethanol

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsDisease AttributesPathologic Processes

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Taha Yaşar Kiraz, MD

    Antalya City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Blinding of participants and the operator was not possible owing to the nature of the intervention. The assessor who recorded outcome measures was blinded to which arm was the intervention arm.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Within-subject (paired) AB/BA crossover: each participant received both conditions on contralateral arms within a single session. Sequence denotes which arm was treated first.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2026

First Posted

August 3, 2026

Study Start

September 15, 2025

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

August 4, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the published results (pain scores, first-attempt success, satisfaction, and skin irritation) will be made available to qualified researchers following approval of a methodologically sound proposal.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Beginning 6 months after publication of the main results and ending 5 years thereafter.
Access Criteria
Requests should be directed to the corresponding author and will be assessed on the basis of the scientific merit of the proposal. Data will be shared after approval and completion of a data sharing agreement.

Locations